Multimodal Prehabilitation in Head and Neck Cancer Patients Undergoing Surgery: A Feasibility Study
Journal of Human Nutrition and Dietetics · 2025-04 · 38 (2)
DOI: 10.1111/jhn.70047 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Human Nutrition and Dietetics, online erschienen am 27.03.2025. Verfasst von Lennaert C B Groen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Northwest clinics, Alkmaar, the Netherlands. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Preoperative Exercise. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was funded by VGZ Health Insurance..
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Head and neck cancer (HNC) incidence is increasing, and surgery is frequently indicated as curative treatment. Unfortunately, complications and long‐term functional impairment are common. Recent promising results of multimodal prehabilitation in colorectal cancer surgery show improved recovery and functional outcomes. The objective of this study is to assess the feasibility of multimodal prehabilitation, which is composed of high‐intensity training, a protein‐enriched diet, cessation of intoxications, mental support and speech support therapy, in HNC surgery.
Methods
A feasibility study was conducted at a large teaching hospital, Northwest Clinics, Alkmaar, the Netherlands, between July 2022 and December 2023. The primary outcome was feasibility, defined as participation, dropout and adherence rate. The secondary outcome was functional capacity 6 weeks postoperatively.
Results
The participation rate was 60% (30 of 50 patients), mainly limited due to the travel distance to the physiotherapist. A dropout rate of 7% was present, as two patients discontinued prehabilitation. Of the remaining 28 patients, 27 patients (96%) attended at least six sessions at the community physiotherapist practice. All functional tests increased by prehabilitation, with the 6‐min walking test being significant ( p ≤ 0.05). Six weeks postoperatively, all but steep ramp tests remained higher than baseline.
Conclusion
Feasibility of multimodal prehabilitation in HNC surgery patients in this study is limited by its participation rate of 60%. Addressing participation, a widespread network of oncologic physiotherapists or home‐based multimodal prehabilitation by an app could possibly potentiate participation. More studies are needed to assess the optimal form of multimodal prehabilitation in this challenging population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Northwest clinics, Alkmaar, the Netherlands.
- Department of Oral and Maxillofacial Surgery, Northwest clinics, Alkmaar, the Netherlands.
- Department of Surgery, Academic University Medical Center location VU, Amsterdam, the Netherlands.
- Department of Surgery, Spaarne Hospital, Haarlem, the Netherlands.
Förderung
- This study was funded by VGZ Health Insurance.
Zitieren
APA
Groen, L. C. B., de Vries, C. D., Mulder, D. C., Daams, F. D., Bruns, E. R. J., Helmers, R., & Schreurs, H. W. H. (2025). Multimodal Prehabilitation in Head and Neck Cancer Patients Undergoing Surgery: A Feasibility Study. Journal of Human Nutrition and Dietetics, 38(2). https://doi.org/10.1111/jhn.70047
Vancouver
Groen LCB, de Vries CD, Mulder DC, Daams FD, Bruns ERJ, Helmers R, et al. Multimodal Prehabilitation in Head and Neck Cancer Patients Undergoing Surgery: A Feasibility Study. Journal of Human Nutrition and Dietetics. 2025;38(2). doi:10.1111/jhn.70047
BibTeX
@article{Groen2025,
author = {Groen, Lennaert C B and de Vries, Celine D and Mulder, Doriene C and Daams, Freek D and Bruns, Emma R J and Helmers, Renée and Schreurs, Hermien W H},
title = {Multimodal Prehabilitation in Head and Neck Cancer Patients Undergoing Surgery: A Feasibility Study},
journal = {Journal of Human Nutrition and Dietetics},
year = {2025},
volume = {38},
number = {2},
doi = {10.1111/jhn.70047}
}
EUVIMED